Market Research Blog – Page 14515 – New Product Development

Perfluoropolyether Market is growing with a healthy CAGR of 4.3% during the forecast period of 2022 – 2029

A new research by Future Market Insights on the perfluoropolyether (PFPE) market includes global industry analysis 2014-2021 and opportunity assessment 2022-2029.

The report explores the perfluoropolyether market and provides the reader with analytical insights for the forecast period of 2019-2029. As per the findings of the report, the global perfluoropolyether market is projected to experience a steady growth over the forecast period, due to multiple driving factors including increasing aerospace, automotive and electronic manufacturing activities across geographies.

The global perfluoropolyether market is estimated to reach US$ 758.8 Mn in 2022, and increase at a CAGR of 4.3% during the forecast period of 2022-2029. This progress in the market is majorly propelled by the growing consumption of perfluoropolyether as lubricants for automotive, chemical and aerospace applications such as wheel bearing and vacuum pump, and for high temperature procedures.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5647

Sensing an increase in new aircraft deployment, especially in developing countries in Asia Pacific, manufacturers are tapping into newer opportunities in the region. Increasing demand for highly efficient lubricants in chemical and automotive industries is further likely to work to the advantage of perfluoropolyether market players.

Europe and North America Lead Gains, South Asia to Offer Greater Opportunities

Although the regions such a Europe and North America are anticipated to hold significant market shares, the South Asia market is expected to project a steady growth in the global perfluoropolyether market over the forecast period of 2022-2029.

Moreover, macroeconomic factors such as increment in GDP, air transportation as well as production, expanding chemical industry and significant growth of the manufacturing sector, are expected to reflect significant increase in opportunities for perfluoropolyether market players in South Asia.

Perfluoropolyether Used Extensively in Aerospace and Automotive Applications

The perfluoropolyether market is categorized into four different segments such as form, application of perfluoropolyether, products, and regions.

By form, the PFPE Oil is expected to hold a higher value as well as volume share against PFPE grease.
By product, the linear perfluoropolyether is projected to attain a significant value shares in the perfluoropolyether market. Linear perfluoropolyethers are widely used as lubricants for the superior chemical properties and multiple applications.
In terms of application, aerospace and automotive sectors will continue to account for relatively high market share. Increasing preference towards non-toxic lubricants from the end users is expected to drive the market. Increasing automotive production is expected to increase the demand for PFPE lubricants. PFPE is also used in other applications such as chemical and electronics, and is recently being used for textile as well as leather applications.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-5647

Perfluoropolyether Market: Players Insights

The perfluoropolyether market report focuses on a number of stakeholders, some of these players have come out as the market leaders. Few examples of such manufacturers in the perfluoropolyether market are as follows; The Chemours Company FC, LLC, Klüber Lubrication München SE & Co. KG, Solvay S.A., TOTAL S.A., M&I Materials Ltd, HUSKEY Specialty Lubricants, Daikin Industries Ltd., and NYE Lubricants Inc. and FluoroTech USA among various others.

The global perfluoropolyether market is highly fragmented, with multiple tier 2 and tier 3 players. Key players provide perfluoropolyether under their trademarked names such as Fomblin® Series, HUSKEY® PF Series, Vertrel™ XF specialty fluid, Vertrel™ MCA Plus specialty fluid®, and DEMNUM®, among others.

Key Segment

By Form

PFPE Oil
PFPE Grease

By Product Type

Linear
Branched

By Application

Automotive
Aerospace
Electronics
Chemical
Others

By Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-5647

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Hydroxypropyl Distarch Phosphate Market is projected to total US$ 2.6 Bn by 2029, FMI

A new market research report by Future Market Insights on the hydroxypropyl distarch phosphate market includes global industry analysis 2014–2021 and opportunity assessment 2022–2029. The report examines the hydroxypropyl distarch phosphate market and provides key perceptions for the forecast period of 2022-2029. As per findings of the report, the global hydroxypropyl distarch phosphate market is projected to witness substantial growth throughout the forecast period, owing to numerous driving factors such as intensifying demand for processed food globally.

The global hydroxypropyl distarch phosphate market was valued at US$ 1.8 Bn in 2022, and is expected to propagate at a CAGR of ~5.8% during the forecast period of 2022-2029. This growth is prominently driven by the growing consumption of hydroxypropyl distarch phosphate in the several end use industries such as food, cosmetics, and pharmaceutical.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3891

According to FMI’s analysis, key manufacturers are focusing on identifying and leveraging the white spaces in the application of hydroxypropyl distarch phosphate. Additionally, market consolidation in developing Asian countries is likely to remain a key to gaining distinct competitive advantage, due to significant growth of cosmetic industry in the region.

Rising East Asia Market Attractiveness

In terms of value, East Asia is projected to consigned lucrative growth in the global hydroxypropyl distarch phosphate market during the forecast period. East Asia is projected to account for dominating region in the global hydroxypropyl distarch phosphate market. Large population and increasing spending power of the residents is driving the processed food market in Asian countries. High GDP growth of India and China has been witnessed in the last few years and is expected to continue during the forecast period.

Moreover, the high growth economies are creating opportunities for food industry to grow at a good pace. Growth in food consumption will ultimately reflect the growth in food additives. Hydroxypropyl distarch phosphate is consumed in processed food in significant quantity. Therefore, high growth in processed food industry is expected to bolster the growth in demand for hydroxypropyl distarch phosphate

Food Industry to Remain as Significant Consumer of Hydroxypropyl Distarch Phosphate

Globally, the Hydroxypropyl Distarch Phosphate market has been segmented on the basis of grade, application, End-Use and regions.

On the basis of grade, the global hydroxypropyl distarch phosphate market is segmented into Halal and Vegan. Halal segment is expected to account for more than 3/4^th share of the total hydroxypropyl distarch phosphate market value throughout the forecast period. Increasing focus of consumer on various standards and certification regarding halal and vegan are expected to drive the global hydroxypropyl distarch phosphate market growth in the upcoming years
On the basis of application, the global hydroxypropyl distarch phosphate market is segmented into anticaking agent, emulsifier, stabilizer, and thickener. Thickener segment is expected to account for prominent share in the global hydroxypropyl distarch phosphate market throughout the forecast period. Increasing demand for thickener in the processed food is projected to boost the demand for hydroxypropyl distarch phosphate in the food industry across the globe
On the basis of end-use, the global hydroxypropyl distarch phosphate market is segmented into food, cosmetics, and pharmaceutical. Food industry is projected to witness lucrative growth and dominating segment in the global hydroxypropyl distarch phosphate market throughout the forecast period. Increased demand for hydroxypropyl distarch phosphate has been observed in industrial applications in cosmetics, pharmaceutical and food & beverages industries. Hydroxypropyl distarch phosphates are mostly used as thickener, emulsifier and stabilizer in these industry.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-3891

Hydroxypropyl Distarch Phosphate Market: Vendor Insights

The report highlights some of the key market participants, who are well-known market leaders in the global hydroxypropyl distarch phosphate market. Some of examples of the key players in the global Hydroxypropyl Distarch Phosphate market are Sinofi Ingredients, Tate & Lyle, Ingredion Incorporated, MGP Ingredients, Inc., Cargill Foods, Shanghai Yu Tao Industrial Co., Ltd., etc. The global hydroxypropyl distarch phosphate market is highly fragmented with number of players holding shares in the market.

Hydroxypropyl Distarch Phosphate Market: Key Segment

By Product Grade

Halal
Vegan

By Application

Anticaking Agent
Emulsifier
Stabilizer
Thickener

By End Use

Food
Cosmetics
Pharmaceutical

By Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-3891

About Future Market Insights (FMI)

Drag Reducing Agent Market is estimated to total US$ 3.74 Bn by 2029, FMI Study

A new market research report by Future Market Insights on the drag reducing agent market includes global industry analysis 2014 – 2021 and opportunity assessment 2022 – 2029.

The global drag reducing agent market is estimated to total US$ 3.74 Bn by 2029, in comparison to the US$ 2.38 Bn registered in 2021. Increasing demand for flow improving products such as drag reducing agents for expanding the flow capacity and enhancing the efficiency of pipelines is favoring the growth in the market.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-8274

Apart from the increasing oil & gas production activities across geographies, the growth is majorly driven by the increasing consumption of drag reducing agent for transportation and logistical applications in pipeline for crude oil, refined products, heavy, asphaltic crude and water transportation purposes in oil & gas, chemicals & petrochemicals, power & energy, agriculture among other industries. FMI expects a promising growth outlook for the market over the course of upcoming decade.

North America’s Market Attractiveness Rising

Regions such as North America and Europe are expected to hold prominent market shares in terms of value. However, the North America market is expected to project lucrative growth in the global drag reducing agent market over the forecast period of 2022-2029.

Furthermore, the effects of macroeconomic factors such as growth in the GDP, growing chemical industry, world oil & gas consumption, crude oil & natural gas production, and rapid industrialization, the confidence of investors and investments in oil & gas projects have increased significantly in North America and other regions as well. As a consequence, the oil field industry of North America, Europe and China has gained a significantly positive momentum over the past years, which has resulted in the growth of pipeline industry as there is a need for increasing distribution network for transportation and exploration of oil products.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-8274

Oil & Gas Industry to Remain as Key Consumer of Drag Reducing Agents

The global market of drag reducing agent has been segmented on the basis of different product types of drag reducing agent, their multiple applications, their end users and regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East and Africa.

By Product type, the polymer type of drag reducing agent segment is expected to hold prominent value shares of the global drag reducing agent market. Polymer drag reducing agents are easily available and compatible with a lot of pipeline exploration machineries, it also falls under bio degradable agents and is also cost effective. On the basis of application, the crude oil and refined products segment are expected to consume majority share of the global drag reducing agent market value.

Drag Reducing Agent Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global drag reducing agent market. Some of the examples of key players in the global drag reducing agent market are Baker Hughes, Liquid Power Specialty Products Inc. (Berkshire Hathaway), The China National Petroleum Corporation, Innospec Incorporated, KMG Chemicals Inc. and Zoranoc Oilfield Chemical Co., Ltd among others.

The global drag reducing agent market is significantly consolidated with some players holding prominent shares of the market. These players are offering drag reducing agent under their popular brands such as LiquidPower®, ExtremePower®, and FLO®, among others.

Key Segment

By Product Type

Polymer
Surfactant
Suspension/ Suspended Solids

By Application

Crude Oil
Multi-phase Liquid
Refined Products
Heavy, Asphaltic Crude
Water Transportation

By End Use

Oil & Gas
Chemicals & Petrochemicals
Power & Energy
Agriculture
Others

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-8274

About Future Market Insights (FMI)

Butyl Glycol Market expanding at a CAGR of 3.6% during the forecast period 2022-2029

The global butyl glycol market is estimated to surpass US$ 3.23 Bn by 2022. Growing application of butyl glycol as a coupling agent and solvent across household cleaning and industrial sectors is propelling the demand in the market.

As per Future Market Insights (FMI), the sales in the butyl glycol market are expected to top US$ 4.14 Bn by the end of 2029, expanding at a CAGR of 3.6% during the forecast period 2022-2029.

Rising demand for paints and coatings is witnessed among the populace of advanced and emerging economies for enhancement of commercial and residential projects, including houses, industrial towers, and others, which is set to drive the butyl glycol market, suggests FMI’s study. In addition, high miscibility and coupling property of butyl glycol with other solvents are making them a great fit for cleaning and maintenance of residential and industrial premises.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-360

The pursuit of an agent with highly favorable physical and chemical characteristics has been amplifying all across the globe. With regulators imposing restrictions on the utilization of butyl glycol due to its hazardous impact on exposure to humans, FMI’s study finds that market players will need to think of a better substitute to comply with changing industrial and consumer trends as well as environmental amendments.

Consumption of Butyl Glycol as a Solvent Superlative

The requirement of butyl glycol as a solvent is unsurpassed, accounting for more than 70% of total market revenue, suggests FMI’s study. Water-based coatings became prominent in 1980s, with about 70% of building trade coatings being water-based as of now. Vinylic and acrylic water-based paints are the most prominent, containing a small amount of organic solvents, such as butyl glycol. Low volatile organic compound (VOC) content of butyl glycol makes it extremely suitable as a solvent in protective surface coatings, including enamels, spray lacquers, and others, as it does not easily evaporate.

Butyl glycol is miscible in all percentages with a majority of organic solvents, for instance, ketones, aromatic paraffin, among others, and water. Owing to its high dilution ratios and excellent solvency, butyl glycol is sought-after in the production and formulation of inks, and varnishes. Slow evaporation rate of butyl glycol enables improved blush resistance, enhanced luster, bettered flow-out and reduced orange-peel in lacquers.

Developing and target countries are witnessing fast-paced growth in groundwork ventures, such as roads, commercial buildings, among others. Upsurge in residential projects for escalating demographic across the globe is propelling the demands for decorative and durable paints. Cleaning of machine components and other assets in industrial vertical is set to contribute to the demand for butyl glycol on account of its high solubility. Furthermore, butyl glycol is creating space in domestic sector as a constituent of cleaning solutions for its high coupling efficiency.

Despite tremendous demand growth, butyl glycol is likely to see a slight decline in the requirement due to its noxious impact on humans upon subjection. Industrial workers reported to have been suffering from chronic illnesses, including nausea, kidney, and liver damage. Further, to curb this problem, regulators are imposing amendments to reduce the use and import of butyl glycol and its parent compound.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-360

Key Segment

By Function

Solvent
Coalescing Aid
Chemical Intermediate
Plasticizer

By Application

Paints and Coatings
Printing Inks
Metal Working Fluid
Polymer & Plastics
Others

By Region

North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-360

The market for butyl glycol is still modest, and this study tracks the growth of butyl glycol market over the period of next decade. The study unfolds how increasing collaboration of stakeholders with local distributors to expand market footprint of butyl glycol will contribute towards the progress of the market. Although North America was the major contributor fueling the growth of butyl glycol market till a few years back, FMI attempts to analyze how the penetration will increase in other regional markets over the course of next decade.

About Future Market Insights (FMI)

Malaria Ag Rapid Testing Market is Set To Witness Rapid Growth by 5% during the Time Period of 2022-2031

According to the latest research by Future Market Insights, Malaria Ag rapid Testing Market is set to experience 5% growth during the year 2021-2031.

Malaria Ag rapid testing kits allows for quick detection of malarial antigen present in human body without the use of microscopes or in lab set-ups.

Primary advantage of using a rapid testing kit is its ease of collection, cost effectiveness, safety and user friendly.

Request for the Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-13904

What is Driving the Demand for Malaria Ag Rapid Testing Market

Malaria Ag rapid testing or rapid diagnostic test are lateral flow immunochromatographic antigen detection test, usually available in test strip or cassette form. These test detect the presence of malarial parasite antigen, in an infected human blood giving results within 15 minutes. Such procedures are simple, safe and easier for quick diagnosis of malaria at an initial stage and does not require special equipment or training.

An increasing number of cases of malaria in tropical countries along with increasing travelers visiting these countries, and in turn getting infected by malaria, can be seen rising in recent years.

Also the unavailability of lab testing for diagnosis of malaria in most endemic countries has further increased the necessity for the malaria antigen rapid tests.

A per the 2019-20 report by World Health Organization (WHO), an estimated 229 Mn cases of malaria was found globally in 87 malaria-endemic countries in 2019.

Of which, 05 countries in Africa region namely, Nigeria (27%), the Democratic Republic of the Congo (12%), Uganda (5%), Mozambique (4%) and Niger (3%), accounted for about 51% of the global cases.

Thus, the demand for the Malaria Ag rapid testing market is likely to provide incremental opportunity in the forecasted period.

Which Factors are likely to Augment the Growth of the Malaria Ag Rapid Testing Market

The field of malaria Ag rapid testing market is witnessing series of advancements and is further expected to offer effective diagnostic solutions for infections caused by malaria.

An increasing number of deaths caused due to non-diagnosis of malaria at early stages and increased resistance of parasite especially

P.falciparum to anti-malarial drugs has increased the need for these rapid diagnostic tests to diagnose the disease at the earliest and provide for treatment of same.

As per the 2019-20 report by World Health Organization (WHO), 67% (274,000) of the total deaths caused by malaria, at global level, consisted of children below 5 years of age, in 2019.

Investment in malaria programs and research & development for malaria control and elimination are being undertaken by government and industry players in various regions. Various Public and private sector organizations are also playing major role in promoting and supporting the clinical development of key products.

A per the 2019-20 report by World Health Organization (WHO), an estimated US$ 3 Bn was the total funding provided for malaria control and elimination.

Out of this total, US$ 900 Mn (31% of total funds) of funding was contributed by the government of endemic countries.

It is thus, expected for the malaria Ag rapid test market to seek a growth in the forecasted period.

North America Malaria Ag Rapid Testing Market Outlook

North America market growth is largely driven by the prevalence of “Airport” Malaria, a common term referring to the malarial infection caused due to the travelling population. Those who visit the malaria-endemic countries and in return get themselves exposed to the infection, resulting in transmission of the infection to the non-infected ones.

As per Centers for Disease Control and Prevention (CDC) report in 2019, approximately 2000 cases of malaria are detected every year in United States.

This is majorly due to increasing number of returning travelers and immigrants coming from countries where malaria transmission happened such as Sub Saharan Africa and South Asia.

Early detection of such cases can reduce future complications as well as risk of transmission associated with the infection. The FDA approved BinaxNOW rapid diagnostic test kit can test for malaria in an individual and help confirm the result.

Alternatively, various policy developments, scientific researches and initiatives, mosquito control programs undertaken by government to eliminate and to reduce the malaria transmission in this segment are expected to further improve the market scenario of Malaria Ag rapid testing.

With increasing number of malaria cases, it is believed to promote the growth of the malaria rapid testing market in the forecasted period.

Europe Demand Outlook for Malaria Ag rapid testing

Europe is anticipated to be the largest market for Malaria Ag rapid testing.

The continuous increase in business related/leisure travels, or migratory movements for employment to and from endemic countries have increased the chances of importing malaria to a malaria-free or non-endemic countries.

As per European Centre for Disease Prevention and Control (ECDC) Annual epidemiological report in 2019, 8641 cases of malarial were reported in Europe region, of which 99% of the cases were confirmed to be travel related infected malaria cases, while the rest 1% was acquired in the Europe.

A trend was observed in travel – related cases when the number of infections increase during or immediately after summer holidays (July –September).

The continuous efforts of government and private players in increasing the awareness about the control and management of malarial cases, growing research and development activities to diagnose malarial causing species in the European region which will further facilitate the growth of the market in the forecasted period.

Who are the key Manufacturers and Suppliers of the Malaria Ag Rapid Testing

Some of the key players of Malaria Ag rapid testing include

Abbott
Accuquik™ Test Kits (USA) Advy Chemical Pvt. Ltd.
Arkray Healthcare Pvt Ltd
CTK Biotech Inc.
Biotrol laboratories Pvt. Ltd.
malarex Limited (UK)
Alere
Ameritek Inc.
Apacor ltd.
Atmo Diagnostics
Biosynex
Boson Biotech Co. Ltd.
HWTAi BioTec
Nectar Lifesciences
standard Diagnostics
TCS Biosciences Ltd
Teco Diagnostics
okchem.com Bio Lab Diagnostics (I) Private Limited
China Tianjin Recare Co., Ltd
Avecon Healthcare Pvt Ltd.

Companies offering Malaria Ag rapid testing are involved in existing product upgrades, new product launches, mergers and collaborations to enhance their market position.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

Malaria Ag Rapid Testing Market Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company

Request for the TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13904

Key Segments

By Product Type:

Test Strip
Cassette

By Distribution Channel:

Drugstore
Retail Pharmacy
Hospital Chain Pharmacy
Online Pharmacy

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Severe Acute Respiratory Syndrome Treatment Market Application, Trends, Growth, Opportunities and Worldwide Forecast to 2028

Severe Acute Respiratory Syndrome Treatment Market: Drivers and Restraints-

Risk factors associated with the spread of severe acute respiratory syndrome include increasing recommendation for combination therapy drugs and increasing prevalence of infectious diseases. These factors will drive the growth of the severe acute respiratory syndrome treatment market. 90% cases of severe acute respiratory syndrome in developing countries and increasing complication rate due to pneumonia and respiratory failures will propel the growth of the severe acute respiratory syndrome treatment market during the forecast period. Increasing research and development and clinical trials and usage of therapeutics for severe acute respiratory syndrome treatment will propel the growth of severe acute respiratory syndrome treatment market. Government initiatives to reduce mortality rate will also be a major factor which will contribute to the growth of the severe acute respiratory syndrome treatment market.

The severe acute respiratory syndrome is caused by the coronavirus which is found in bats and palm civets in Southern China. The severe acute respiratory syndrome is a serious life-threatening viral infection. Its symptoms includes cough, chills and shaking, headache, muscle aches, diarrhoea, nausea, vomiting and dizziness. The severe acute respiratory syndrome first appeared in 2003 and spread rapidly. This infection can spread easily from one person to another via respiratory droplets if they come in contact with skin or mucous membranes. In October 2012, the severe acute respiratory infection was added to National Select Agent Registry, which regulates the handling and control of bacteria, viruses and toxins that have the capability to pose a severe risk to public health and safety. Risk of atypical pneumonia, pulmonary fibrosis and respiratory failure are the major risk factors associated with the severe acute respiratory syndrome. Antivirals and antibiotics are recommended for treatment of severe acute respiratory syndrome. However, an antibiotic treatment, in most cases, is not enough to treat severe acute respiratory syndrome treatment; supportive care is also required.Severe Acute Respiratory Syndrome Treatment Market: Overview

Severe acute respiratory syndrome treatment therapeutic drugs involve a broad-spectrum of antibiotics and supportive care as well as immunomodulatory therapy and antiviral agents. Some antibiotics have immunomodulatory properties. For instance, quinolones and macrolides are prescribed for severe acute respiratory syndrome treatment. The Ribavirin antiviral drug was majorly chosen as an empirical therapy for severe acute respiratory syndrome. It is the most commonly used antiviral with corticosteroids. Corticosteroids have been the main immunomodulatory therapy used for severe acute respiratory syndrome treatment. Thymosin alpha 1 is also administrated to treat severe acute respiratory syndrome treatment, especially in China. Thymosin alpha 1 is a relatively safe product and enhances T-cell function.

Severe Acute Respiratory Syndrome Treatment Market: Region-wise Outlook

In terms of geography, the severe acute respiratory syndrome treatment market has been divided into seven regions — North- America, Eastern Europe, Western Europe and Asia- Pacific excluding China & Japan (APECJ), Japan Middle-East & Africa and Latin America. North America is the dominating segment in the severe acute respiratory syndrome treatment market due to rising awareness regarding infectious diseases and increasing drug manufacturing facilities. In Western Europe, Germany, France and the UK will be the fastest growing regions in the severe acute respiratory syndrome treatment market due to strengthening laws and government guidelines covering infectious diseases. APEJ region includes two fastest developing countries — India and China — which will prove to be the most promising markets for severe acute respiratory syndrome treatment market players due to factors like increasing government initiatives to reduce disease complication and high incidences of diseases in China.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6866

Severe Acute Respiratory Syndrome Treatment Market: Key Market Participants

Example of some key market participants in the global severe acute respiratory syndrome treatment market are Novartis AG, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC., Reckitt Benckiser Group plc, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Merck & Company, Inc., Abbott Laboratories and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (India, ASEAN, Australia & New Zealand)
China
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6866

Severe Acute Respiratory Syndrome Treatment Market: Segmentation

On the basis of drug type, the severe acute respiratory syndrome treatment market can be segmented into:

Antiviral
Antibacterial
Immunomodulators drugs

On the basis of route of administration, the severe acute respiratory syndrome treatment market can be segmented into:

Oral
Injectable

On the basis of distribution channel, the market can be segmented into:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6866

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Oncology Blood Testing Market Growth Share, Industry Dynamics, Top Trends and Regional Analysis Forecast to 2027

Oncology Blood Testing: Market Dynamics

Increasing capability of early detection of cancer via oncology blood tests that enables instant treatment decisions, growing prevalence of cancer among people over the globe, increasing production of oncology blood testing assays and kits with capability of being efficient diagnostic tool for cancer detection in blood are some of the major factors expected to drive the growth of oncology blood testing market. Introduction of rapid and technologically advanced liquid biopsy assay, growing awareness about less invasive blood diagnostic tests and increased expenditure in oncology blood screening R&D activities is further propelling the growth of oncology blood testing market. Also, rise in demand for oncology blood testing in the hospitals and diagnostic laboratories is also expected to drive the growth of market. However, large number of diagnostic tools to detect cancer using blood sample are still under development and clinical trial stage, and are not available commercially, thereby restraining the oncology blood testing market growth.

Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool. Unlike conventional invasive biopsies, liquid biopsies involve blood drawn from the body of suspected patient and is less invasive as compared to the conventional biopsies. As cancer is a life-threatening, it has to be diagnosed in time and proper treatment should be given in order to be treated. A wide range of oncology blood tests are available in the market to screen cancerous cells in the blood. Some major types of blood tests for detection of cancer includes complete blood count test, blood protein test, tumor marker test, CTC – based test, non-invasive prenatal test, liquid biopsy assays, and exam-based liquid biopsy and thereby contribute majorly to the revenue generation in oncology blood testing market. Also, oncology blood testing find vast applications in early stage diagnosis of various life-threatening cancers including lung cancer, breast cancer, colon cancer, ovarian cancer and others. The latest research and advancements in human genome sequencing has enabled researchers to diagnose the genetic mutations of distinct cancers. The advanced human genome sequencing with the ability to detect cancerous cells in the blood volume is anticipated to generate large revenues in the oncology blood testing market. The liquid biopsies are done commercially but on a limited basis to detect and treat Stage III or Stage IV cancers. A large number of liquid biopsy tests are currently under clinical trials and would be commercialized soon in the coming years, fuelling the revenue growth in global oncology blood testing market. However, based on the end users, these oncology blood tests are performed largely in hospitals, diagnostic laboratories and specialty clinics.To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6449

Oncology Blood Testing Market: Key Players

Some of the key players present in global Oncology Blood testing market are Guardant Health Inc., Trovagene Inc., Genomic Health Inc., Foundation Medicine Inc., Exosome Diagnostics, Pathway Genomics Corporation and others.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6449

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Oncology Blood Testing Market: Segmentation

The global oncology blood testing market is segmented by test type, application and end user:

Segmentation by Test Type

CBC (Complete Blood Count) Test
Blood Protein Test
Tumor Marker Test
CTC (Circulating Tumor Cells) – based Test
NIPT (Non-Invasive Prenatal Testing) Test
Liquid Biopsy Assays
Exom-Based Liquid Biopsy

Segmentation by Application

Lung Cancer
Breast Cancer
Colon Cancer
Melanoma
Ovarian Cancer
Gastro-Intestinal Stromal Tumor (GIST)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6449

Segmentation by End User

Hospitals
Specialty Clinics
Diagnostic Laboratories

Ultrasound Imaging Solution Market Analysis, Recent Trends and Regional Growth Forecast by 2027

Ultrasound Imaging is an essential diagnostic tool that utilizes high frequency sound waves to generate visual images of internal organs, blood flow or tissues inside the human body. The high frequency sound waves emitted out of an ultrasound device are transmitted to the affected area under examination. The transmitted waves after striking the organ surface returns back in form of eco and are received by the physician, thereby producing a dynamic live image of the focused organ. Unlike X-ray imaging, ultrasound imaging does not involve usage of any ionizing radiation or nephrotoxic contrast agents. In comparison with the other medical imaging modalities, ultrasound imaging is capable of providing real-time, cost-effective and non-invasive imaging that is done via easy-to-use, and portable device. Due to the rising prevalence of cardiac disorders and internal damage, ultrasound imaging solution market registers a robust growth. The ultrasound imaging find major applications in point-of-care diagnostics that enables immediate diagnosis of a disease, patient’s hemodynamic conditions and internal tissue damage. These imaging solutions are highly used in emergency rooms, ambulances and battlefield.Based on the type of software, ultrasound imaging solution market has been categorized in to two different types including integrated software and standalone software. However, on the basis of imaging type, the ultrasound imaging can be performed as 2D, 3D/4D and Doppler imaging. Followed by application, ultrasound imaging being an elemental diagnostic tool used to evaluate, diagnose and treat different medical conditions, found large scale applications. Some of the major applications include cardiology, obstetrics & gynaecology, nephrology & urology, orthopedic, dental, oncology and radiology.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6448

Ultrasound Imaging Solution Market: Region-wise Outlook

On the basis of geography, global ultrasound imaging solution market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. North America holds the largest revenue shares in the global ultrasound imaging solution market on the account of increasing footprint of developed pharmaceutical companies and increased launch of commercialized products. However, Asia-Pacific is anticipated to register the highest growth in ultrasound imaging solution market during the forecast period due to the rising healthcare expenditure and continual upgradation in infrastructure and technology. Also, Western Europe is anticipated to register a moderate growth in global ultrasound imaging solution market over forecast period.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6448

Ultrasound Imaging Solution: Market Dynamics

Rise in prevalence of chronic diseases such as cardiovascular diseases and poor patient diagnosis imaging is driving the urgency to adopt ultrasound image analysis software so as to improve the disease diagnosis. Also, increasing geriatric population coupled with growing prevalence for cardiovascular diseases and high advantages over convention imaging techniques are some of the key factors driving the growth of ultrasound imaging solution market. The ability to generate high quality image and perform real time volumetric imaging is further boosting ultrasound imaging solution market across the globe. However, moving forward, the integration of these solutions while enhancing their diagnostic capabilities is expected to be a challenging task for ultrasound imaging solution market growth.

Ultrasound Imaging Solution Market: Key Players

Some of the key players present in global Ultrasound Imaging Solution market are GE Healthcare, Philips Healthcare, MIM Software, Inc., Merge Healthcare Incorporated, Esaote SpA, Xinapse Systems Ltd, MIM Software, Inc., Spacelabs Healthcare, Inc. and others

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Ultrasound Imaging Solution Market: Segmentation

The global Ultrasound Imaging Solution market is segmented on the basis of software types, imaging type, application, end user and region:

Segmentation by Software Type

Integrated Software
Standalone Software

Segmentation by Imaging Type

2D Ultrasound Imaging
3D/4D Ultrasound Imaging
Doppler Imaging

Segmentation by Application

Cardiology
Obstetrics & Gynecology
Nephrology & Urology
Orthopedic
Dental
Oncology
Radiology
Others

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/6448

Segmentation by End User

Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers

Glaucoma Therapeutics Market Industry Analysis, Opportunities, Technology, Demand, Top Players and Growth Forecast 2027

Glaucoma Therapeutics Market: Overview

Glaucoma Therapeutics market is expected show exponential growth over the forecast period due to increasing prevalence of glaucoma throughout the globe. According to the journal published at NCBI, glaucoma is the leading cause of blindness among the people worldwide. By treatment type, medication eye drops segment will hold the maximum market share for the global glaucoma therapeutic market due to its high preference by the physician for medication during the early stages of treatment. Laser surgery is more preferred than tradition surgery by booth surgeon and the patients owing to the low risk of failure. By glaucoma type, closed glaucoma will dominate the maximum market share attributed to its more prevalence then open glaucoma.

Glaucoma Therapeutics Market: Drivers and RestraintsThe change in the lifestyle of people has resulted in the rise in the prevalence of glaucoma globally. Increasing prevalence of glaucoma is the primary factor driving the growth of glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. Rising geriatric population thought the globe is also responsible for the robust growth of glaucoma therapeutics market over the forecast period. Increasing preference of physician towards the laser surgery for the treatment of glaucoma will propel the growth of glaucoma therapeutics market over the forecast period. Less awareness among the people about the glaucoma treatment will deter the growth of glaucoma therapeutics market to some extent. Moreover, lack of availability of skilled professional for laser surgery in under developing economies will also hamper the growth of glaucoma therapeutics market.

Glaucoma is the eye disease that damage the patient eye nerve optics. The formation extra fluid up in the front part of the eye results the damage to eye nerve optics. Glaucoma is of two type, primary open-angle glaucoma and angle-closure glaucoma which is also referred as closed-angle glaucoma or narrow-angle glaucoma. Open-angle glaucoma is the most common type glaucoma. Primary glaucoma gradually happens when the eye does not drain the fluids. This result the building of pressure on eye nerve optics. Open glaucoma causes no change in the eye vision and it is painless too. Closed-angle glaucoma happens very close to the drainage angle which results the blocking of drainage angle of eyesight. This is a very acute type of glaucoma. This type of glaucoma may affect the vision of the patient and it may cause severe pain to the eye and the headache. Glaucoma is generally treated with eye drops, pill, traditional surgery, laser surgery and sometimes the combination of these methods. The aim of glaucoma treatment is to avoid the vision loss of patient wherever if the vision of particular patient is already lost then it is irreversible by glaucoma treatment. Regular consumption of medication as prescribed by the physician is very necessary for the proper treatment of glaucoma. The drugs of glaucoma have very fewer chances of effects which has increased it adoption the global market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6456

Glaucoma Therapeutics Market: Key Players

Some of player across the value chain of Glaucoma Therapeutics market are Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer and Santen and others.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6456

Glaucoma Therapeutics Market: Segmentation

The global Glaucoma Therapeutics market is classified on the basis of treatment type, glaucoma type, and geographic region.

Based on treatment type, Glaucoma Therapeutics market is segmented into following:

Eye Drops
Medication
Laser Surgery
Traditional Surgery

Based on glaucoma type, Glaucoma Therapeutics market is segmented into following:

Open-angle glaucoma
Closed-angle glaucoma

Wireless Handheld Spectrometer Market is Booming Worldwide by 2028 | Growth, Share, Demand and Analysis Forecasts

Factors Driving the Growth of the Wireless Handheld Spectrometer Market

The need for quick results and potable systems is increasing the demand for wireless handheld spectrometer. For instance, the requirement of small handheld device that can scan substances and highlight the chemical composition in raw materials in the pharmaceutical and life science industry. This will reduce the considerable amount of time required for testing of theses substance in the lab. Significant technological advancements enable the development of low-cost devices. One of the major drawbacks of these devices is the limited range of test and sensitivity that may hinder the market growth to some extent.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/wireless-handheld-spectrometer-market

FTIR, NIR and Raman spectrometers are very common in a majority of R&D facilities. Spectrometers are used to for a number of applications that include identification of bulk materials, checking contamination, ensuring intermediates are processing as expected and for confirming that the final product is within the required specifications. However, most of these spectrometers are confined to the lab as they are large but not portable. Thus, it would take at least two days for a sample to be sent to the lab, get processed and reports to be presented. With the introduction of the wireless handheld spectrometers the results can now be available almost instantly on a smart phone. A number of companies such as Phison Group (UPRtek), Carl Zeiss and Thermo Fisher Scientific offer a number of such wireless handheld spectrometers.Advancement in the Wireless Handheld Spectrometry through Handheld Mass Spectrometer

For all testing such as environmental testing, food testing, forensic testing, chemical analysis, and others, mass spectrometry is the best tool available. However, these devices are large and confined to the lab and thus may take a long time for the results to be available. BaySpec offers one such device called the Portability Transportable Mass Spectrometer. The device is small enough to be used in the field and yet offer ppb-level detection. MIT further has planned to develop a mass spectrometer of the size of a smart phone. Miniaturizing the mass spectrometer has a very large potential and will aid the market growth of the wireless handheld spectrometers.

Competition Outlook

Small-Scale Manufacturers/Providers	Medium-Scale Manufacturers/Providers	Large-Scale Manufacturers/Providers
Designs and Prototypes MIDAC Corp Grabner Instruments Surface Optics Corp GASMET technologies	Pasco Corporation Bruker Daltonics, Inc	Phison Group (UPRtek) Carl Zeiss Hamilton Sundstrand Applied Instrument Technologies Thermo Fisher Scientific

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6723

Research Methodology

FMI/PMR utilizes a triangulation methodology that is primarily based on overall expenditure on life science research and R&D funding and capital equipment installed base to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country-specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of kits, reagents and consumables among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

By Product Type

FTRI
NIR
Raman
Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6723

By Applications

Material Chemistry
Drug Discovery
Life Science
Forensic Science
Environmental testing
Food and Agriculture
Others

By Region

North America
Western Europe
Eastern Europe
Latin America
Asia Pacific
Japan
Middle East & Africa

Report Highlights:

Shifting industry dynamics
In-depth market segmentation
Key competition landscape, market structure and regulatory scenario
Availability of wireless handheld spectrometers
key players and product offerings, sales, marketing and channel strategies,
Regional and channel foot print
A neutral perspective towards market performance in terms of market value